Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Understanding hereditary diseases using the dog and human as companion model systems.

ABSTRACT: Animal models are requisite for genetic dissection of, and improved treatment regimens for, human hereditary diseases. While several animals have been used in academic and industrial research, the primary model for dissection of hereditary diseases has been the many strains of the laboratory mouse. However, given its greater (than the mouse) genetic similarity to the human, high number of naturally occurring hereditary diseases, unique population structure, and the availability of the complete genome sequence, the purebred dog has emerged as a powerful model for study of diseases. The major advantage the dog provides is that it is afflicted with approximately 450 hereditary diseases, about half of which have remarkable clinical similarities to corresponding diseases of the human. In addition, humankind has a strong desire to cure diseases of the dog so these two facts make the dog an ideal clinical and genetic model. This review highlights several of these shared hereditary diseases. Specifically, the canine models discussed herein have played important roles in identification of causative genes and/or have been utilized in novel therapeutic approaches of interest to the dog and human.

SUBMITTER: Tsai KL

PROVIDER: S-EPMC1998873 | biostudies-other | 2007 Jul

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Similar Datasets

The companion dog as a model for human aging and mortality.

Project description:Around the world, human populations have experienced large increases in average lifespan over the last 150 years, and while individuals are living longer, they are spending more years of life with multiple chronic morbidities. Researchers have used numerous laboratory animal models to understand the biological and environmental factors that influence aging, morbidity, and longevity. However, the most commonly studied animal species, laboratory mice and rats, do not experience environmental conditions similar to those to which humans are exposed, nor do we often diagnose them with many of the naturally occurring pathologies seen in humans. Recently, the companion dog has been proposed as a powerful model to better understand the genetic and environmental determinants of morbidity and mortality in humans. However, it is not known to what extent the age-related dynamics of morbidity, comorbidity, and mortality are shared between humans and dogs. Here, we present the first large-scale comparison of human and canine patterns of age-specific morbidity and mortality. We find that many chronic conditions that commonly occur in human populations (obesity, arthritis, hypothyroidism, and diabetes), and which are associated with comorbidities, are also associated with similarly high levels of comorbidity in companion dogs. We also find significant similarities in the effect of age on disease risk in humans and dogs, with neoplastic, congenital, and metabolic causes of death showing similar age trajectories between the two species. Overall, our study suggests that the companion dog may be an ideal translational model to study the many complex facets of human morbidity and mortality.

| S-EPMC5946068 | biostudies-other

Human iPSCs as Model Systems for BMP-Related Rare Diseases.

Project description:Disturbances in bone morphogenetic protein (BMP) signalling contribute to onset and development of a number of rare genetic diseases, including Fibrodysplasia ossificans progressiva (FOP), Pulmonary arterial hypertension (PAH), and Hereditary haemorrhagic telangiectasia (HHT). After decades of animal research to build a solid foundation in understanding the underlying molecular mechanisms, the progressive implementation of iPSC-based patient-derived models will improve drug development by addressing drug efficacy, specificity, and toxicity in a complex humanized environment. We will review the current state of literature on iPSC-derived model systems in this field, with special emphasis on the access to patient source material and the complications that may come with it. Given the essential role of BMPs during embryonic development and stem cell differentiation, gain- or loss-of-function mutations in the BMP signalling pathway may compromise iPSC generation, maintenance, and differentiation procedures. This review highlights the need for careful optimization of the protocols used. Finally, we will discuss recent developments towards complex in vitro culture models aiming to resemble specific tissue microenvironments with multi-faceted cellular inputs, such as cell mechanics and ECM together with organoids, organ-on-chip, and microfluidic technologies.

| S-EPMC10487005 | biostudies-literature

Synergy-COPD: a systems approach for understanding and managing chronic diseases.

Project description:Chronic diseases (CD) are generating a dramatic societal burden worldwide that is expected to persist over the next decades. The challenges posed by the epidemics of CD have triggered a novel health paradigm with major consequences on the traditional concept of disease and with a profound impact on key aspects of healthcare systems. We hypothesized that the development of a systems approach to understand CD together with the generation of an ecosystem to transfer the acquired knowledge into the novel healthcare scenario may contribute to a cost-effective enhancement of health outcomes. To this end, we designed the Synergy-COPD project wherein the heterogeneity of chronic obstructive pulmonary disease (COPD) was addressed as a use case representative of CD. The current manuscript describes main features of the project design and the strategies put in place for its development, as well the expected outcomes during the project life-span. Moreover, the manuscript serves as introductory and unifying chapter of the different papers associated to the Supplement describing the characteristics, tools and the objectives of Synergy-COPD.

| S-EPMC4255903 | biostudies-other

Hereditary cancer syndromes as model systems for chemopreventive agent development.

Project description:Research in chemoprevention has undergone a shift in emphasis for pragmatic reasons from large, phase III randomized studies to earlier phase studies focused on safety, mechanisms, and utilization of surrogate endpoints such as biomarkers instead of cancer incidence. This transition permits trials to be conducted in smaller populations and at substantially reduced costs while still yielding valuable information. This article will summarize some of the current chemoprevention challenges and the justification for the use of animal models to facilitate identification and testing of chemopreventive agents as illustrated though four inherited cancer syndromes. Preclinical models of inherited cancer syndromes serve as prototypical systems in which chemopreventive agents can be developed for ultimate application to both the sporadic and inherited cancer settings.

| S-EPMC10433689 | biostudies-literature

Longevity of companion dog breeds: those at risk from early death.

Project description:The companion dog is one of the most phenotypically diverse species. Variability between breeds extends not only to morphology and aspects of behaviour, but also to longevity. Despite this fact, little research has been devoted to assessing variation in life expectancy between breeds or evaluating the potential for phylogenetic characterisation of longevity. Using a dataset of 584,734 unique dogs located within the UK, including 284,734 deceased, we present variation in longevity estimates within the following: parental lineage (purebred = 1 breed, crossbred ≥ 2 breeds), breed (n = 155), body size (large, medium, small), sex (male, female) and cephalic index (brachycephalic, mesocephalic, dolichocephalic). Survival estimates were then partitioned amongst phylogenetic clades: providing evidence that canine evolutionary history (via domestication and associated artificial selection) is associated with breed lifespan. This information provides evidence to inform discussions regarding pedigree health, whilst helping current/prospective owners, breeders, policy makers, funding bodies and welfare organisations improve decision making regarding canine welfare.

| S-EPMC10834484 | biostudies-literature

Hereditary Thoracic Aortic Diseases.

Project description:Advances in both imaging techniques and genetics have led to the recognition of a wide variety of aortic anomalies that can be grouped under the term 'hereditary thoracic aortic diseases'. The present review aims to summarize this very heterogeneous population's clinical, genetic, and imaging characteristics and to discuss the implications of the diagnosis for clinical counselling (on sports activity or pregnancy), medical therapies and surgical management.

| S-EPMC10795846 | biostudies-literature

Regulating Companion Dog Welfare: A Comparative Study of Legal Frameworks in Western Countries.

Project description:There appear to be growing concerns among experts, NGOs, and members of the public about the welfare of companion dogs. With farm and laboratory animals, legislative initiatives have long been considered valuable tools in the management of welfare whereas the use of legislation to protect companion animal welfare has received less attention. We aim to rectify this by comparing legislation with an impact on the welfare of companion dogs in eleven Western jurisdictions. The comparison also provides a basis for further consideration of regulatory initiatives. We identify the rules applying in the jurisdictions and classify them in accordance with the following categories: breeding of dogs with risks to the health of the offspring, reproductive limitations, sales, surgical interventions, day-to-day handling, and killing. We demonstrate that, overall, there is significant variation across the jurisdictions. However, the degree of variation depends on the specific category. Whereas most countries, with the USA being a notable exception, regulate sales of dogs and ban surgical interventions, there is considerable variation in the regulation of day-to-day handling and the killing of dogs. Furthermore, different jurisdictions employ different regulatory tools to ensure the desired level of welfare for companion dogs. Overall, there appears to be real potential for dialogue and mutual inspiration.

| S-EPMC8228344 | biostudies-literature

Duty of care in companion dog owners: Preliminary scale development and empirical exploration.

Project description:Owner behaviour change may be the most promising avenue to improve dog welfare. As such, understanding potential drivers of owner behaviour is critical to developing effective intervention programs. Here we examine in depth the concept of "duty of care" as a motivator of owner behaviour. Using a mixed methods approach, this study aimed to better understand the potential dimensions of duty of care, their interrelationships, and develop psychometrically valid tools to measure them in companion dog owners. This was achieved through a multi-stage process including a critical literature review, qualitative interviews (n = 13), and an online survey (n = 538). Using Schwartz's Norm Activation Model as a framework, we have developed a 30 item scale with 5 subscales; duty beliefs, problem awareness, awareness of impact, efficacy, and ascription of responsibility. These unique subscales demonstrate good internal consistency and construct validity. In addition to developing a measurement tool, this process has provided important insights into the nature of duty of care in companion dog owners, creating several avenues for future inquiry. One such finding was that many dog welfare problems may not be the result of lacking duty beliefs, but rather weaknesses in other "activation" factors such as problem awareness or ascription of responsibility. Further work is now required to understand the predictive validity of the scale and the relative influence of its different dimensions on owner behaviour and dog welfare outcomes. This will facilitate the identification of appropriate targets for intervention programs aimed at improving owner behaviour and consequently, dog welfare.

| S-EPMC10191305 | biostudies-literature

Predicting molecular mechanisms of hereditary diseases by using their tissue-selective manifestation.

Project description:How do aberrations in widely expressed genes lead to tissue-selective hereditary diseases? Previous attempts to answer this question were limited to testing a few candidate mechanisms. To answer this question at a larger scale, we developed "Tissue Risk Assessment of Causality by Expression" (TRACE), a machine learning approach to predict genes that underlie tissue-selective diseases and selectivity-related features. TRACE utilized 4,744 biologically interpretable tissue-specific gene features that were inferred from heterogeneous omics datasets. Application of TRACE to 1,031 disease genes uncovered known and novel selectivity-related features, the most common of which was previously overlooked. Next, we created a catalog of tissue-associated risks for 18,927 protein-coding genes (https://netbio.bgu.ac.il/trace/). As proof-of-concept, we prioritized candidate disease genes identified in 48 rare-disease patients. TRACE ranked the verified disease gene among the patient's candidate genes significantly better than gene prioritization methods that rank by gene constraint or tissue expression. Thus, tissue selectivity combined with machine learning enhances genetic and clinical understanding of hereditary diseases.

| S-EPMC10407743 | biostudies-literature

Systems biology of interstitial lung diseases

Project description:This SuperSeries is composed of the following subset Series: GSE21369: Gene expression profiles of interstitial lung disease (ILD) patients GSE21394: MicroRNA expression profiles of interstitial lung disease (ILD) patients Refer to individual Series

2011-04-19 | E-GEOD-21411 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data